"Designing Growth Strategies is in our DNA"

Spinal Muscular Atrophy (SMA) Treatment Market Size, Share & Industry Analysis, By Product (Nusinersen and Onasemnogen Abeparvovec), By Disease Type (Type 1 SMA, Type 2 SMA and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100576

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Spinal Muscular Atrophy for Key Countries
    2. Key Industry Developments
    3. Pipeline Analysis
    4. New Product Launches
    5. Reimbursement Scenario by Key Countries
    6. Regulatory Scenario
    7. Key Industry Trends
  5. Global Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis, Insights and Forecast – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    5. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    5. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
  10. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. Biogen
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Genentech, Inc./ F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Astellas Pharma Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Genzyme Corporation
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
Read Less

Figure 1:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018 & 2026

Figure 3:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Nusinersen, 2015-2026

Figure 4:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Onasemnogen Abeparvovec, 2015-2026

Figure 5:  Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018 & 2026

Figure 6:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Type 1 SMA, 2015-2026

Figure 7:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Type 2 SMA, 2015-2026

Figure 8:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 9:  Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 10:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 11:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 12:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 13:  Global Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Region, 2018 & 2026

Figure 14:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2018 & 2026

Figure 15:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018

Figure 16:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 17:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018

Figure 18:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 19:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 20:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country, 2018 & 2026

Figure 21:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country, 2018

Figure 22:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2018 & 2026

Figure 23:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018

Figure 24:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 25:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018

Figure 26:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 27:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 28:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 29:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 30:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2018 & 2026

Figure 31:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018

Figure 32:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 33:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018

Figure 34:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 35:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 36:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 37:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 38:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2018 & 2026

Figure 39:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018

Figure 40:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 41:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018

Figure 42:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 43:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 44:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 45:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 46:  Global Spinal Muscular Atrophy (SMA) Treatment Market Share (%), By Company, 2018

Table 1:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015–2026

Table 2:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015–2026

Table 3:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 6:  North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 7:  North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 10:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 11:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 14:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 15:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 18:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 19:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Spinal Muscular Atrophy Treatment Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase